ROYCE & ASSOCIATES LPROYCE & ASSOCIATES LP

Institutional investor · Portfolio as of Q4 2022

SEC EDGAR SourceSEC Filings

Top Holdings906 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
KWKWDelisted

KENNEDY-WILSON HOLDINGS INC

6.5M$102.3M1.1%$14.07-7.45%
16 qtrssince 2019-Q1
Increased
52
ALALDelisted

AIR LEASE CORP

2.5M$97.4M1.0%$32.25+12.88%
16 qtrssince 2019-Q1
Decreased
0
884,650$92.8M1.0%$83.18+24.59%
16 qtrssince 2019-Q1
Decreased
0

ZIFF DAVIS INC

1.2M$91.1M1.0%$91.10-13.17%
16 qtrssince 2019-Q1
Increased
42

INNOSPEC INC

870,736$89.6M0.9%$79.57+23.24%
16 qtrssince 2019-Q1
Decreased
0

VALMONT INDUSTRIES

270,388$89.4M0.9%$129.04+149.75%
16 qtrssince 2019-Q1
Decreased
0

SEI INVTS CO

1.5M$84.7M0.9%$54.04+3.73%
16 qtrssince 2019-Q1
Decreased
0

ARCOSA INC

1.5M$83.2M0.9%$38.96+38.26%
16 qtrssince 2019-Q1
Decreased
0

KADANT INC

430,390$76.5M0.8%$93.86+85.98%
16 qtrssince 2019-Q1
Decreased
0

QUAKER CHEMICAL CORPORATION

454,616$75.9M0.8%$175.80-9.39%
16 qtrssince 2019-Q1
Increased
45

LINCOLN ELECTRIC HOLDINGS

509,767$73.7M0.8%$76.84+80.27%
16 qtrssince 2019-Q1
Increased
42

INTERPARFUMS INC

760,138$73.4M0.8%$55.39+62.19%
16 qtrssince 2019-Q1
Decreased
0

MARCUS & MILLICHAP INC

2.1M$73.1M0.8%$35.66-7.56%
16 qtrssince 2019-Q1
Increased
43

MKS INC

847,815$71.8M0.8%$94.37-12.49%
16 qtrssince 2019-Q1
Increased
44

INGLES MKTS INC

738,286$71.2M0.7%$60.59+54.63%
8 qtrssince 2021-Q1
Increased
42

LINDSAY CORP

426,361$69.4M0.7%$89.75+74.99%
16 qtrssince 2019-Q1
Decreased
0

FORRESTER RESH INC

1.9M$69.2M0.7%$37.42-4.44%
16 qtrssince 2019-Q1
Increased
42

KBR INC

1.3M$68.4M0.7%$18.53+175.83%
16 qtrssince 2019-Q1
Decreased
0

RALPH LAUREN CORP

624,931$66M0.7%$89.84+11.50%
11 qtrssince 2020-Q2
Decreased
0
HAHAE

HAEMONETICS CORP MASS

825,462$64.9M0.7%$79.85-1.50%
13 qtrssince 2019-Q4
Decreased
0
$9.5B
AUM
906
Positions
Q4 2022
Filing
Rating · 2.5
Quarterly Portfolio Change
-8%Q3'21$13.4B+0%Q4'21$13.4B-12%Q1'22$11.8B-18%Q2'22$9.7B-9%Q3'22$8.8B+8%Q4'22$9.5B
Activity profile
$ moved · Q4'22
New10%Increased41%Decreased39%Exited10%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.8 years
<1Q4%1-4Q9%1-2Y10%2Y+77%

ROYCE & ASSOCIATES LP manages $9.5B across 906 positions as of Q4 2022. Top holdings: KW (1.1%), AL (1.0%), FWRD (1.0%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.

Q4 2022 Summary

Active quarter - 75 new positions, 98 exits, 347 increased. Top move: KW (INCREASED, conviction 52). Portfolio: $9.5B across 906 positions.

Top holdings by portfolio weight

Total AUM$10B
KW1.07%
AL1.02%
FWRD0.98%
ZD0.96%
IOSP0.94%
VMI0.94%
SEIC0.89%
ACA0.87%
KAI0.80%
KWR0.80%
Other0.77%

Portfolio allocation by GICS sector

Sectors11
Industrials25.50%
Technology16.38%
Financial Services12.00%
Consumer Cyclical11.87%
Unknown9.19%
Basic Materials7.25%
Healthcare6.12%
Real Estate3.39%
Consumer Defensive3.29%
Communication Services2.91%
Other2.10%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Industrials, Technology, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record69
Conviction31
Concentration14
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BFSTBFSTBUSINESS FIRST BANCSHARES IN
Q3 2024 Q2 2026+581,481 shares+$21M
8Q
CVLGCVLGCOVENANT LOGISTICS GROUP INC
Q3 2024 Q2 2026+275,648 shares+$11.8M
8Q
LABLABSTANDARD BIOTOOLS INC
Q3 2024 Q2 2026+4.2M shares+$3.2M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used